LENZ Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
LENZ Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q2 2025.
  • LENZ Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $2.85M, a 78.1% increase year-over-year.
  • LENZ Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $9.22M, a 159% increase year-over-year.
  • LENZ Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $6.37M, a 374% increase from 2023.
  • LENZ Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.34M, a 90.1% decline from 2022.
  • LENZ Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13.5M, a 71.9% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $9.22M $2.85M +$1.25M +78.1% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-30
Q1 2025 $7.97M $2.56M +$1.61M +170% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $6.37M $1.63M +$1.11M +215% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-19
Q3 2024 $5.25M $2.19M +$1.7M +344% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $3.56M $1.6M +$1.41M +745% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-30
Q1 2024 $2.15M $947K +$805K +567% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 $1.34M $518K -$3.1M -85.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-19
Q3 2023 $4.45M $494K -$2.72M -84.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $7.16M $189K -$3.17M -94.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $10.3M $142K -$3.2M -95.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $13.5M $3.62M +$1.18M +48.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $12.4M $3.21M +$836K +35.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $11.5M $3.36M +$1.34M +66.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $10.2M $3.34M +$2.31M +224% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $7.87M $2.45M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 $2.37M +$2.34M +6494% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $2.02M +$2.02M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.03M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $36K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $1K* Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.